Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 2B: Randomized Double-Blinded Clinical Study of Chondrogen for Treatment of Knee Osteoarthritis

NCT04520945 is registered in ClinicalTrials.gov with Meluha Life Sciences SDN BHD as lead sponsor.

NCT NCT04520945
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04520945 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 2B: Randomized Double-Blinded Clinical Study of Chondrogen for Treatment of Knee Osteoarthritis
Lead sponsor
Meluha Life Sciences SDN BHD
Phase
Phase 2
Overall status
Unknown status
Start date
October 31, 2020
Completion date
September 30, 2022
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

osteoarthritis, knee